Tower Research Capital LLC (Trc) Tarsus Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 485 shares of TARS stock, worth $26,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
485
Previous 5,844
91.7%
Holding current value
$26,073
Previous $158,000
90.51%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TARS
# of Institutions
173Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$183 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$176 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$134 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$131 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$121 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.43B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...